KCL researchers identify key features of autoimmune diseases present in the gut
Globally affecting 4% of the population, autoimmune diseases mistakenly attack healthy cells, tissues and organs in the body
Read Moreby Jen Brogan | May 20, 2024 | News | 0
Globally affecting 4% of the population, autoimmune diseases mistakenly attack healthy cells, tissues and organs in the body
Read Moreby Jen Brogan | Apr 29, 2024 | News | 0
The method has the potential to be used to deliver RNA to the bloodstream for a range of diseases
Read Moreby Jen Brogan | Apr 26, 2024 | News | 0
The paper identifies the roles and differences between LARP4A and LARP4B in sarcoma and carcinoma cancers
Read Moreby Jen Brogan | Apr 24, 2024 | News | 0
According to the World Health Organization, CVDs are responsible for an estimated 17.9 million deaths every year
Read Moreby Jen Brogan | Apr 22, 2024 | News | 0
The launch is part of the NIHRs £42m funding to establish 14 new HRCs across England
Read Moreby Jen Brogan | Apr 12, 2024 | News | 0
Both partners’ will leverage their nuclear research facilities and expertise to develop new health interventions
Read Moreby Jen Brogan | Apr 11, 2024 | News | 0
RTIs account for around 60% of global antibiotic prescribing and are a key driver of AMR
Read Moreby Jen Brogan | Apr 5, 2024 | News | 0
Hoxa9 and b-catenin molecules are a rare population of self-renewing HSCs found in bone marrow
Read Moreby Jen Brogan | Apr 4, 2024 | News | 0
The project will assist researchers and companies in training the technology for healthcare settings
Read Moreby Jen Brogan | Mar 21, 2024 | News | 0
The globally fast-growing progressive neurological condition affects around 153,000 people in the UK
Read Moreby Jen Brogan | Mar 19, 2024 | News | 0
The SOL3D pipeline addresses research challenges in relation to equipment, expertise and cost
Read Moreby Jen Brogan | Mar 11, 2024 | News | 0
The HYPIEND project consists of 14 partners from eight European countries
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479